Patterns of care in adjuvant systemic therapy of patients with stage III melanoma: A U.S. population-based study.

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

As new variants of the SARS-CoV-2 virus continue to emerge, concerns have been raised about the performance of rapid antigen tests. The team, which was funded by NIH's Rapid Acceleration of ...

Bryan Tieman is a Principal Scientist in the Diagnostics Division of Abbott Laboratories (IL, USA) and is a member of the Biologics Discovery Group where he creates binding agents and targets for the ...

Using the LightCycler 480 System for Discovery and Analysis of Genetic Variation LightCycler® Real-time PCR Systems from Roche (www.roche.com) are efficient platforms for genetic variation research.

One reason that researchers do not always find specific DNA sequence variations in genes associated with muscular dystrophy (MD) is that they lack a reliable and cost-effective assay to detect point ...

University of Hawaii professor Tao Yan, left, from the Department of Civil and Environmental Engineering, along with postdoctoral researchers Doris Di and Bo Li, collect wastewater samples to analyze ...